Dr. Hubert Birner
Chairman
Pharmaceutical science
Noxxon Pharma
United States of America
Biography
Dr. Birner is Managing Partner at TVM Capital’s Munich and Montreal offices. He is responsible for numerous active investments in Europe as well as the United States. He currently serves as chairman of the board of AL-S Pharma (Zürich, Switzerland), Argos Therapeutics Inc. (Durham, North Carolina), leon-nanodrugs GmbH (Munich, Germany) and Spepharm Holdings BV (Amsterdam, The Netherlands) and is a member of the board of directors of Proteon Therapeutics, Inc. (Boston, Massachusetts). Over many years, he was the chairman/vice chairman of Direvo Biotech AG (Cologne, Germany) and Jerini AG (Berlin, Germany), which were acquired in 2008 by Bayer HealthCare AG and Shire Ltd., respectively.
Research Interest
Pharmaceutical science
